Basile, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 1.791
EU - Europa 1.382
AS - Asia 505
OC - Oceania 14
SA - Sud America 14
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.716
Nazione #
US - Stati Uniti d'America 1.784
SE - Svezia 456
IT - Italia 275
CN - Cina 206
SG - Singapore 137
DE - Germania 132
IE - Irlanda 120
PL - Polonia 104
FR - Francia 71
ID - Indonesia 70
RU - Federazione Russa 48
GB - Regno Unito 43
FI - Finlandia 41
IN - India 36
UA - Ucraina 27
BE - Belgio 13
TR - Turchia 12
CZ - Repubblica Ceca 10
AU - Australia 9
BR - Brasile 9
HK - Hong Kong 9
ES - Italia 8
NL - Olanda 8
CI - Costa d'Avorio 7
IR - Iran 7
JP - Giappone 6
CA - Canada 5
NZ - Nuova Zelanda 5
VN - Vietnam 5
BY - Bielorussia 4
DK - Danimarca 4
KR - Corea 4
PT - Portogallo 4
CH - Svizzera 3
CL - Cile 3
KZ - Kazakistan 3
RO - Romania 3
GR - Grecia 2
HU - Ungheria 2
MX - Messico 2
PH - Filippine 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
EU - Europa 1
IL - Israele 1
KH - Cambogia 1
MC - Monaco 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
PY - Paraguay 1
Totale 3.716
Città #
Chandler 492
Ashburn 203
Dublin 119
Warsaw 104
Singapore 103
New York 99
Jakarta 70
San Mateo 62
Rome 53
Fairfield 52
Wilmington 45
Marseille 42
Princeton 42
Boston 39
Moscow 37
Milan 35
Ann Arbor 30
Nanjing 30
Helsinki 29
Cattolica 28
Jacksonville 28
Boardman 27
Beijing 25
Seattle 24
Woodbridge 22
Bremen 21
Dearborn 21
Houston 20
Redwood City 20
Bologna 14
Castelnuovo di Val di Cecina 14
Falls Church 14
Los Angeles 13
Hebei 12
Norwalk 12
Brussels 10
Edinburgh 10
Shenyang 10
Tianjin 10
Atlanta 9
Cambridge 9
Nanchang 9
Brno 8
Hong Kong 8
Lancaster 8
Leawood 8
Munich 8
Abidjan 7
Augusta 7
Izmir 7
Chicago 6
Jiaxing 6
Lawrence 6
London 6
Redmond 6
Berlin 5
Kunming 5
Lappeenranta 5
Palermo 5
Pune 5
São Paulo 5
Washington 5
Amsterdam 4
Auckland 4
Esslingen am Neckar 4
Guangzhou 4
Hangzhou 4
Hounslow 4
Kish 4
Lanzhou 4
Melbourne 4
Minsk 4
Nürnberg 4
Paris 4
Brisbane 3
Busan 3
Busto Arsizio 3
Changsha 3
Codroipo 3
Dallas 3
Hanoi 3
Jinan 3
Muravera 3
Novato 3
Nuremberg 3
Priverno 3
San Diego 3
San Jose 3
Shanghai 3
Tokyo 3
Afyonkarahisar 2
Alatri 2
Almaty 2
Baotou 2
Bari 2
Ben Arous 2
Bern 2
Borgonovo Val Tidone 2
Brooklyn 2
Budapest 2
Totale 2.310
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 283
Overview of immune abnormalities in lysosomal storage disorders 101
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 97
Evaluation of screening method for Bence Jones protein analysis 93
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 92
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 89
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 81
Immunological role of IgG subclasses 81
Comparison between the traditional and a rapid screening test for cryoimmunoglobulins detection 80
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 78
Pre-analytical phase in cryoglobulin (CRG) detection: an alternative method for sample transport 76
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 76
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 76
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 75
Immunological role of IgG subclasses 74
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 71
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 70
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 68
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 67
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 66
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 66
The Laboratory Role in anti-TNF Biological Therapy Era 64
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 64
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 63
Heavy chain disease: Our experience 63
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 63
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 62
Anti-nuclear antibody detection in cryoprecipitates: Distinctive patterns in hepatitis C virus-infected patients 61
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 60
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 60
IgG cryoglobulinemia 59
Cryoglobulins: putative effectors of adaptive immune response 58
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 57
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 57
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 56
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 55
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 55
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 53
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 53
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 52
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 51
Free light chains and autoimmunity 51
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 51
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 48
COVID-19, adaptative immune response and metabolic-associated liver disease 48
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 46
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 44
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 37
Serum free light chain quantitative assays: Dilemma of a biomarker 35
Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy 34
Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity 32
Antenna-enhanced mid-infrared detection of extracellular vesicles derived from human cancer cell cultures 29
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 29
SARS-CoV-2 was already circulating in Italy, in early December 2019 29
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 27
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 26
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 26
The dark side of current analytic methods for Bence Jones Proteinuria 26
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 24
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 23
Sensing red blood cell nano-mechanics: Toward a novel blood biomarker for Alzheimer’s disease 23
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 20
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 18
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 16
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 15
SCREENING FOR THE IDENTIFICATION OF AUTOIMMUNE OR LYMPHOPROLIFERATIVE ONSET IN PATIENTS NAiVE TO HCV ANTIVIRAL TREATMENT 14
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 12
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 12
Type 2 cytokines and scleroderma interstitial lung disease 12
Calprotectin: two sides of the same coin 9
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 8
Totale 3.850
Categoria #
all - tutte 19.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.893


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020207 0 0 0 24 18 29 42 8 11 33 35 7
2020/2021264 26 14 10 9 33 11 8 6 18 17 70 42
2021/2022492 23 11 5 72 38 18 12 76 24 22 80 111
2022/20231.395 204 179 90 212 89 151 84 121 148 20 73 24
2023/2024839 35 194 12 85 26 161 67 34 6 43 72 104
2024/2025288 60 50 118 60 0 0 0 0 0 0 0 0
Totale 3.850